Company Overview and News

6
Genworth Financial (GNW): Strong Industry, Solid Earnings Estimate Revisions

2018-07-09 zacks
One stock that might be an intriguing choice for investors right now is Genworth Financial, Inc. (GNW - Free Report) . This is because this security in the Insurance - Life Insurance space is seeing solid earnings estimate revision activity and is in great company from a Zacks Industry Rank perspective. This is important because, often times, a rising tide will lift all boats in an industry, as there can be broad trends taking place in a segment that are boosting securities across the board.
CVRR GNW FSLR

14
3 Ideas - July 2018 - Buy American

2018-07-06 seekingalpha
(Courtesy of the Wolfsonian-FIU Library, Mr. & Mrs. Francis Luca, and The Buy American Act of 1933)
CWH DDS PATI GNW PAT FRPH

14
Three Ideas - July 2018 - Buy American

2018-07-06 seekingalpha
(Courtesy of the Wolfsonian-FIU Library, Mr. & Mrs. Francis Luca, and The Buy American Act of 1933)
CWH DDS PATI GNW PAT FRPH

15
GNW / Genworth Financial, Inc. FORM 8-K (Current Report)

2018-06-28 sec.gov
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
GNW

44
Zacks Industry Outlook Highlights: GWG Holdings, FGL Holdings, American Equity Investment Life Holding, Genworth Financial and Primerica

2018-06-28 zacks
Chicago, IL – June 28, 2018 – Today, Zacks Equity Research discusses the Industry: Life Insurers, including GWG Holdings, Inc. (GWGH - Free Report) , FGL Holdings (FG - Free Report) , American Equity Investment Life Holding Company (AEL - Free Report) , Genworth Financial, Inc. (GNW - Free Report) and Primerica, Inc. (PRI - Free Report) .
ROP WLL LXFR WCG WTW ICHR JOUT PRI TWIN SEDG GWGH GNW FG

18
Worsening trade row deepens chill felt by Chinese dealmakers seeking to do US takeovers

2018-06-28 moneycontrol
The rapidly deteriorating trade and investment relationship between Washington and Beijing is sending a further chill through Chinese dealmakers who have already seen the number of Chinese acquisitions of American assets take a big hit.
MGI TRI GNW

18
Life Insurers Outlook: Prospects Paint a Bright Picture

2018-06-28 zacks
Improving rate environment and a favorable employment backdrop should keep the momentum alive in the life insurance space. Given the accelerated pace of rate hikes, life insurers should witness a boost in their investment income. The Federal Reserve’s rate hike in June 2018 marks the seventh increase since December 2015. The Central Bank has announced intentions of two more raises this year with three lined up in 2019 and a couple of in 2020.
PRI GWGH GNW FG

18
Future Prospects Brighter For Brighthouse Financial

2018-06-27 seekingalpha
Brighthouse Financial was spun-off from Metlife in 2017, representing much of the retail-oriented aspects of the insurance giant.
BHF VOYA MET GNW

18
Worsening trade row deepens chill felt by Chinese dealmakers seeking to do US takeovers - Channel NewsAsia

2018-06-27 channelnewsasia
The rapidly deteriorating trade and investment relationship between Washington and Beijing is sending a further chill through Chinese dealmakers who have already seen the number of Chinese acquisitions of American assets take a big hit.
MGI TRI GNW

17
Worsening trade row deepens chill felt by Chinese dealmakers seeking to do U.S. takeovers

2018-06-27 reuters
HONG KONG (Reuters) - The rapidly deteriorating trade and investment relationship between Washington and Beijing is sending a further chill through Chinese dealmakers who have already seen the number of Chinese acquisitions of American assets take a big hit.
MGI GNW

23
GNW / Genworth Financial, Inc. FORM 11-K

2018-06-25 sec.gov
Form 11-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
GNW

1384
Weekly Commentary: Performance Chase

2018-06-24 seekingalpha
The Nasdaq Composite, Nasdaq 100, small cap Russell 2000, Value Line Arithmetic and the NYSE Arca Biotechnology were among U.S. indices trading to all-time highs during Wednesday's session. In the real world, there is escalating risk of a destabilizing global trade war. The Shanghai Composite sank 4.4% this week to two-year lows. It was another week of instability for emerging market equities, bonds and currencies - especially in Asia.
LOW SYMC SIG AKRX KMX CHKVP UAA RL TWX CHKVZ SAM ASNA GM.WS.A TWTR GM.WS.B GM.WS.C CHK.PRD RCII CMCSK TWC FOSL NDAQ NTXFF CHK FL GM.WSB BA HBI CCV CONN NFLX AMD CCZ NTXFY CHKDH CHKDG FMCKI FMCKJ CHKDJ KR CHKDP BOE AAPL KSS SWN GM CKRGZ FMCCO FMCCP FMCCM FMCCN CMCSA TRIP FMCCI FMCCJ CVNA M FMCCG FMCKO NYTAB FMCKP FMCKM IWM FMCKN FMCKK FMCKL CHKWZ SIG W UA LHHMQ FMCC MU CCV.CL CHK.WI TSLA KN MNK GNW FIVE FMCCS FMCCT

15
If you're in your 50s, you need to plan for long-term care right now

2018-06-22 cnbc
More money doesn't always lead to more planning, especially when it comes to unpopular subjects like end-of-life care.
GNW

130
SA Interview: Chris DeMuth Jr. On First United And ETF Reconstitutions

2018-06-20 seekingalpha
Chris DeMuth Jr. is the founder of Rangeley Capital, an investment firm that focuses on event driven, value-oriented investment opportunities.
HNNA BBX TWX NXPI CVS TWC FUNC T AUBN ZN CI GNW AET JASO

222
Merger Arbitrage Mondays - June 18, 2018

2018-06-19 seekingalpha
Merger activity increased last week with two new deals announced and five pending deals closing. Several deals with large spreads on account of regulatory hurdles including Bayer's acquisition of Monsanto, AT&T's (NYSE:T) acquisition of Time Warner and China Oceanwide's acquisition of Genworth (NYSE:GNW) recently managed to get past those hurdles.
CAVM MRVL STDY RAD TWX NXPI WGL SXE MCHP TWC MSCC T CALL GNW QCOM GGP

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to GNW / Genworth Financial, Inc. on message board site Silicon Investor.

Cognigen:CGNW GNWR: Genesee u0026 Wyoming, Inc.
UNDERVALUED GEM - GNWR - P.E. = 9 / E.P.S. = 2.20
CUSIP: 37247D106